LCTX · Forms 3, 4, 5
Insider trades at Lineage Cell Therapeutics, Inc.
No open-market insider buys or sells at Lineage Cell Therapeutics, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Lineage Cell Therapeutics, Inc. (LCTX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Lineage Cell Therapeutics, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Neal C Bradsher | Director | Options or other derivatives | Form 4 | ||||
| Anula Jayasuriya | Director | Options or other derivatives | Form 4 | ||||
| Michael H. Mulroy | Director | Options or other derivatives | Form 4 | ||||
| Deborah J Andrews | Director | Options or other derivatives | Form 4 | ||||
| Angus C. Russell | Director | Options or other derivatives | Form 4 | ||||
| Dipti Amin | Director | Options or other derivatives | Form 4 | ||||
| Brian M Culley | President and CEO | Buy | 15,000 | $1.63 | $24K | Form 4 | |
| Brian M Culley | President and CEO | Options or other derivatives | Form 4 | ||||
| Jill Ann Howe | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| George A. Samuel III | General Counsel and Secretary | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.